A detailed history of Marshall Wace, LLP transactions in Conmed Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 7,401 shares of CNMD stock, worth $520,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,401
Previous 75,415 90.19%
Holding current value
$520,734
Previous $5.23 Million 89.82%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.09 - $76.92 $4.36 Million - $5.23 Million
-68,014 Reduced 90.19%
7,401 $532,000
Q2 2024

Aug 14, 2024

BUY
$61.9 - $80.36 $1.38 Million - $1.79 Million
22,326 Added 42.05%
75,415 $5.23 Million
Q1 2024

May 15, 2024

BUY
$75.36 - $112.51 $1.27 Million - $1.9 Million
16,876 Added 46.6%
53,089 $4.25 Million
Q4 2023

Feb 14, 2024

BUY
$91.3 - $115.05 $1.98 Million - $2.49 Million
21,685 Added 149.26%
36,213 $3.97 Million
Q3 2023

Nov 14, 2023

BUY
$97.55 - $135.91 $1.42 Million - $1.97 Million
14,528 New
14,528 $1.47 Million
Q1 2023

May 15, 2023

BUY
$89.75 - $107.27 $552,501 - $660,354
6,156 New
6,156 $639,000
Q3 2020

Nov 16, 2020

SELL
$69.87 - $89.2 $8.43 Million - $10.8 Million
-120,705 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$50.31 - $81.76 $1.31 Million - $2.13 Million
-26,102 Reduced 17.78%
120,705 $8.69 Million
Q1 2020

May 15, 2020

BUY
$39.81 - $112.01 $5.84 Million - $16.4 Million
146,807 New
146,807 $8.41 Million
Q3 2019

Nov 14, 2019

SELL
$83.97 - $102.19 $13.4 Million - $16.3 Million
-159,433 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$78.27 - $86.94 $18.7 Million - $20.8 Million
-239,289 Reduced 60.01%
159,433 $13.6 Million
Q1 2019

May 14, 2019

BUY
$60.79 - $83.18 $14.5 Million - $19.8 Million
238,500 Added 148.86%
398,722 $33.2 Million
Q4 2018

Feb 14, 2019

BUY
$57.41 - $79.06 $9.2 Million - $12.7 Million
160,222 New
160,222 $10.3 Million

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.14B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.